Orderly meds provides access to proven GLP one medications like somaglutide and tirzepatide, including both name brand options and personalized compound versions when appropriate.
Orderly Meds: Podcast advertising · May 22–Jun 9, 2026
ChurnedOrderly Meds advertising observed across this podcast campaign.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Shows
Where the campaign appearedPlacements
Categories
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
Less support through telehealth, but it feels overwhelming and rushed? Check out orderlymeds.com now. Orderlymeds.com was built to be different. Here, you connect with real doctors who take the time to understand your goals, review your eligibility, and guide you through a plan that's right for you. Orderly meds provides access to proven GLP one medications like somaglutide and tirzepatide, including both name brand options and personalized compound versions when appropriate. So you have choices backed by clinical oversight, not guesswork. It's a simpler, more supportive telehealth experience designed around people who want clarity, care, and confidence in their weight loss journey. And your medication is delivered directly to your home in discreet packaging, packaging, so your experience stays private from start to finish.
More campaigns from Orderly Meds
Other published campaigns from this sponsor
Orderly Meds connects users with licensed providers for GLP-1 weight loss medications online, presenting the service as a convenient solution for those seeking a new approach to health and weight management.
The campaign highlights the convenience of accessing GLP-1 medications through virtual telemedicine with licensed professionals to help individuals achieve their wellness goals.
Orderly Meds advertising observed across this podcast campaign.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.